Incannex Healthcare (IXHL) Change in Account Payables (2023 - 2024)

Incannex Healthcare (IXHL) posted quarterly Change in Account Payables of $2.7 million for Q2 2024, up 69.22% year-on-year from $1.6 million in Q3 2023, and up 1447.03% on a QoQ basis from -$202000.0 in Q1 2024.

Incannex Healthcare (IXHL) Change in Account Payables (2023 - 2024) Analysis & Trends

Incannex Healthcare (IXHL) has reported Change in Account Payables for 2 consecutive years, with $2.7 million the latest figure, recorded in Q2 2024.

  • Quarterly Change in Account Payables rose 69.22% year-over-year to $2.7 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $4.3 million (changed N/A YoY) and the FY2024 annual result came in at $3.0 million, up 173.82% from the prior year.
  • Change in Account Payables grew to $2.7 million in Q2 2024 per IXHL's latest filing, from -$202000.0 in the prior quarter.
  • Over the last five years, Change in Account Payables for IXHL reached as high as $2.7 million in Q2 2024 and fell as low as -$202000.0 in Q1 2024.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 62.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 30.60 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 32.70 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Incannex Healthcare 3.63 Mn 3.63 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2024 2.72 Mn
Jun 30, 2024 2.72 Mn
Mar 31, 2024 -202,000.00
Mar 31, 2024 -202,000.00
Jun 30, 2023 1.61 Mn
Jun 30, 2023 1.61 Mn
Mar 31, 2023 131,000.00
Mar 31, 2023 131,000.00